Buscar por Autor be0238a9-b65c-49e3-aa6c-b68e8ba81f78
Mostrando resultados 1 a 3 de 3
Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![TFM - Santiago López Gil.pdf.jpg](/jspui/retrieve/542af9bd-7f49-40c8-80d0-ebe3181a00b0/TFM%20-%20Santiago%20L%c3%b3pez%20Gil.pdf.jpg) | 25-ago-2022 | Estudio observacional descriptivo sobre las secuelas respiratorias en pacientes ingresados por COVID-19 en el Hospital General Universitario de Elda | López Gil, Santiago | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/jspui/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone.naxolone versus tapentadol in real world chronic non‑cancer pain.pdf.jpg](/jspui/retrieve/6dff66a3-3891-4c74-9646-8c79f0d0e88e/Oxycodonenaloxone.naxolone%20%20versus%20tapentadol%20in%20real%20world%20chronic%20non%e2%80%91cancer%20pain.pdf.jpg) | 2022 | Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María | ![](/image/openAccess.png) |